Doctors With Vision
The PERL team
Young Nuclear Medicine physicians, Hematologists and Radiotherapists
The PERL team is composed by young Nuclear Medicine physicians, Haematologists and Radiotherapists, with national and international experience on clinical and research activities on PET/CT in lymphoma. The project PI is Salvatore Annunziata, MD, PhD, Nuclear Medicine physician and head of TracerGLab GSTeP, an institutional research facility dedicated to PET/CT radiopharmaceuticals. During the project, other personnel will be involved such as a dedicated fellow in TracerGLab GSTeP and a data analyst in Radiomics GSTeP.
What are we doing
No studies have been published on the prognostic role of radiomic features derived from baseline 18F-FDG-PET/CT in a large cohort of high-grade lymphoma.
This project aims to gap this knowledge, studying a large dataset of patients in our referral university hospital by an experienced multidisciplinary team. The retrospective nature of this project enables to
collect a large dataset of patients with lymphoma with a long-term follow-up, useful to evaluate the prognostic power of volumetric and radiomic features using the conventional reference standards in lymphoma.